A series of cases of HIV and acute Hepatitis B coinfection – treatment issues

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Progress in roll-out of generic dolutegravir-based treatment in Georgia

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Avidity of antibodies to Hepatitis C virus in persons with newly diagnosed HCV infection

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Latvia on its’ way to achieve WHO plan to eliminate Hepatitis C by 2030

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Co-infections with Hepatitis virus B and C among patients with human immunodeficiency virus in a regional center of HIV/AIDS from northeastern Romania

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Hepatitis C virus treatment response to sofosbuvir/ledipasvir among adolescents coinfected with HIV and HCV: Real world data from Ukraine

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Associations between HLA Class II- DRB1 Alleles with susceptibility to Viral Hepatitis B and C in patients with HIV infection

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Occult HBV infection and two clinical cases with malignant comorbidities

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Randomized control trial of home-based Hepatitis C self-testing in key populations in Georgia

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Prevalence of Hepatitis among the general population in Botswana from the STI microbial survey of 2017/2018

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Simplified ART regime on the background of multi-allergy in an elderly HIV-infected patient

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

SARS-CoV-2 Vaccine Boosting - Penny Moore, PhD

COVID-19 Clinical Forum 2021

SARS-CoV-2 Vaccine Boosting - Penny Moore, PhD (September Edition)

COVID-19 Clinical Forum 2021

SARS-CoV-2 Immunity in People with HIV and Other Immunosuppressed Individuals - J. Frater, FRCP, PhD

COVID-19 Clinical Forum 2021

SARS-CoV-2 Immunity in People with HIV and Other Immunosuppressed Individuals - J. Frater, FRCP, PhD (September Edition)

COVID-19 Clinical Forum 2021

Update on COVID-19 Therapeutics - Daniel Kuritzkes, MD (September Edition)

COVID-19 Clinical Forum 2021

Leveraging Reverse Transcriptase in HIV 2021 - Laura Waters

Leveraging Reverse Transcriptase in HIV 2021

Update on COVID-19 Therapeutics | Daniel Kuritzkes, MD (September Edition)

COVID-19 Clinical Forum 2021

HIV Drug Resistance - Bench to Bedside - Leon Levin, MBBCh(Wits), FCPaed(SA), DTM&H

INTEREST 2021 (FR)

HIV Cure – Where Are We - Casper Rokx, MD, PhD

INTEREST 2021 (FR)

James Hakim Memorial Lecture - Access to COVID-19 Vaccines in Africa Situational Analysis and Local Manufacturing Options - John Nkengasong, PhD

INTEREST 2021 (FR)

Management of Virological Failure within the African Setting - Chijioke Umunnakwe, PhD

INTEREST 2021 (FR)

PrEP in Africa - The Future - Elizabeth Anne Bukusi, MBChB, M.Med (ObGyn), MPH, PhD, PGD (Research Ethics), MBE (Bioethics), CIP

INTEREST 2021 (FR)

New HIV Prevention Methods for Women - Nyaradzo Mgodi, MBChB, MMed

INTEREST 2021 (FR)